These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10212906)

  • 1. What have been the strategies for the registration, positioning and control of medical information for intramuscular artemether?
    Helenport JP; Roche G
    Med Trop (Mars); 1998; 58(3 Suppl):73-6. PubMed ID: 10212906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positioning, labelling and control of medical information: artesunate strategy and Arsumax development story.
    Moneton P; Ducret JP
    Med Trop (Mars); 1998; 58(3 Suppl):70-2. PubMed ID: 10212905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positioning, labelling, and medical information control of co-artemether tablets (CPG 56697): a fixed novel combination of artemether and benflumetol. Novartis Co-Artemether International Development Team.
    Skelton-Stroud P; Mull R
    Med Trop (Mars); 1998; 58(3 Suppl):77-81. PubMed ID: 10212907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What role can public health institutions play in drug development for the poor? A case study of artesunate.
    Gomes M; Olliaro P; Folb P
    Med Trop (Mars); 1998; 58(3 Suppl):97-100. PubMed ID: 10212912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
    Checkley AM; Whitty CJ
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemether vs quinine therapy in Plasmodium falciparum malaria in Manipur--a preliminary report.
    Singh NB; Bhagyabati Devi S; Singh TB; Singh MA; Singh NB
    J Commun Dis; 2001 Jun; 33(2):83-7. PubMed ID: 12170942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR.
    Taylor WR; Rigal J; Olliaro PL
    J Vector Borne Dis; 2003; 40(3-4):65-72. PubMed ID: 15119074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin and its derivatives: the regulatory and policy implications for African countries.
    Salako L
    Med Trop (Mars); 1998; 58(3 Suppl):82-4. PubMed ID: 10212908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemether for severe malaria: a meta-analysis of randomized clinical trials.
    Pittler MH; Ernst E
    Clin Infect Dis; 1999 Mar; 28(3):597-601. PubMed ID: 10194084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative clinical trial of artemether and quinine in children with severe malaria.
    Huda SN; Shahab T; Ali SM; Afzal K; Khan HM
    Indian Pediatr; 2003 Oct; 40(10):939-45. PubMed ID: 14581730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open study to evaluate the efficacy of artemether in severe falciparum malaria.
    Sharma P; Swarup D; Saxena GN; Bhandari S; Sharma UB; Tuteja R
    J Assoc Physicians India; 1999 Sep; 47(9):883-5. PubMed ID: 10778657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports.
    Sahr F; Willoughby VR; Gbakima AA; Bockarie MJ
    Ann Trop Med Parasitol; 2001 Jul; 95(5):445-9. PubMed ID: 11487367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The view of the pharmaceutical industry.
    Roche G; Helenport JP
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S57-8. PubMed ID: 8053031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Dicko A; Djimde A; Guindo O; Kone M; Tolo Y; Thera MA; Sogoba M; Fofana M; Ouattara A; Sissoko M; Jansen HF; Doumbo OK
    Am J Trop Med Hyg; 2006 Oct; 75(4):630-6. PubMed ID: 17038684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.